Scopia Holdings LLC and Matthew Sirovich Acquire 9.9% Stake in PAVmed Inc. (PAVM)

On April 13, 2026, Scopia Holdings LLC and Matthew Sirovich filed a Schedule 13G disclosing a new significant ownership stake in PAVmed Inc. (PAVM). As of the event date on March 27, 2026, Scopia Holdings LLC reported beneficial ownership of 630,118 shares of Common Stock, representing approximately 9.9% of the company. Matthew Sirovich, as a member of Scopia Holdings LLC, is deemed to beneficially own a total of 637,670 shares, which includes the holdings of Scopia Holdings plus an additional 7,552 shares over which he has individual power to direct the vote and disposition. This filing marks a significant new position for the reporting persons, as previous ownership was reported at 0.0%. The filing was made under Rule 13d-1(c), indicating a passive investment intent without the purpose of changing or influencing the control of the issuer. Both reporting persons maintain sole voting and dispositive power over their respective reported shares.